Pharmaceutical Technology

DECEMBER 9, 2024

Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.

122

122

MedCity News

DECEMBER 9, 2024

Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is helping multiple myeloma patients live longer compared to treatment with blockbuster Johnson & Johnson drug Darzalex. The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to Blenreps return to the market.

FDA 109

FDA Leads Marketing Patients 109

Pharmaceutical Technology

DECEMBER 9, 2024

Citryll has secured an oversubscribed Series B funding round, raising 85m ($89.8m) to advance the clinical development of CIT-013.

105

105

MedCity News

DECEMBER 9, 2024

Swiss Medtech Company Medacta teamed up with Geisinger to begin providing the world’s first, lifetime guarantee on shoulder replacement surgeries. The post A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger appeared first on MedCity News.

108

108

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmaceutical Technology

DECEMBER 9, 2024

The US FDA has granted priority review to AstraZeneca's sBLA for Imfinzi (durvalumab) for muscle-invasive bladder cancer (MIBC) treatment.

FDA 105

FDA 105

Copyright Clearance Center

DECEMBER 9, 2024

Richard Charkin makes his first trip to the Charleston Conference of scholarly librarians and publishers.

97

97

Referral MD

DECEMBER 9, 2024

Prior authorization is a pivotal component of healthcare, bridging the relationship between patients, healthcare providers, and insurance companies. While it can seem complex and frustrating, prior authorization is vital in balancing quality care and cost efficiency. This blog outlines the essentials of prior authorization what it is, why it exists, the steps involved, and how the process can be improved.

Healthcare 82

Healthcare Healthcare Insurance Healthcare Provider 82

PharmaTimes

DECEMBER 9, 2024

Trial results lead to new treatment option for lung cancer

Leads 90

Leads 90

MedCity News

DECEMBER 9, 2024

Cala Health closed a $50 million funding round. The Silicon Valley-based company sells an FDA-cleared wearable device that temporarily relieves hand tremors in people with essential tremor and Parkinsons disease. The post Cala Health Snags $50M for At-Home Tremor Relief Therapy appeared first on MedCity News.

FDA 99

FDA 99

PharmaTimes

DECEMBER 9, 2024

promising pre-clinical data on preventing cytokine release syndrome

Pharma 87

Pharma 87

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

MedCity News

DECEMBER 9, 2024

With evidence generated in minutes, the days of broad-based guidelines will be gone, as researchers and clinicians will have personalized evidence at their fingertips that can transform value-based care. The post How AI Can Close the Gap in Evidence-Based Care appeared first on MedCity News.

Medicine 92

Medicine Healthcare Healthcare 92

Contrarian Sales Techniques

DECEMBER 9, 2024

When people think of medical sales, they often picture a rep armed with clinical data and technical knowledge, pitching the latest pharmaceutical product or medical device. But what truly sets successful reps apartespecially in multinational pharmaceutical companies (MNCs) is not just what they know, but how they connect. Soft skills, often underestimated, are the secret sauce behind thriving in this fast-paced, relationship-driven industry.

Medical sales 52

Medical sales Medical Sales Medical sales reps 52

MedCity News

DECEMBER 9, 2024

A webinar on Thursday, December 12 from Noon to 1 pm ET will focus on how companies are meeting these challenges. The post How Can Employers Give Staff the Best Care Amidst Rising Healthcare Costs? appeared first on MedCity News.

Healthcare 70

Healthcare Healthcare 70

Pharmacy Times

DECEMBER 9, 2024

Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.

59

59

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

DECEMBER 9, 2024

The breakthrough designation for Daiichi Sankyo comes after early pooled results from two ongoing trials finding the drug was well tolerated.

59

59

Pharmacy Times

DECEMBER 9, 2024

Pharmacists play a key role in vaccination efforts to prevent respiratory illnesses.

55

55

Pharmaceutical Technology

DECEMBER 9, 2024

Novo Holdings, the investment arm of the Novo Nordisk Foundation, has gained approval from the EC for its acquisition of Catalent.

59

59

Pharmacy Times

DECEMBER 9, 2024

Luca Bertamini, MD highlights the potential clinical implications of using circulating tumor cells as a biomarker in patients with newly-diagnosed multiple myeloma.

Patients 55

Patients 55

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Veeva

DECEMBER 9, 2024

Customer engagement in the life sciences industry has evolved dramatically in the last several years, owing to new blended models of engagement that leverage content for more fruitful, virtual interactions. Despite this, many in the industry have not fully grasped the importance of balance. Balancing the digital and physical engagement approach through a true omnichannel strategy, and understanding how critical the channel mix is for commercial teams, is still something that our industry needs t

Healthcare 52

Healthcare Biopharma Healthcare Marketing 52

Pharmacy Times

DECEMBER 9, 2024

The phase 3 CEPHEUS trial demonstrated that adding daratumumab (DARA) to the VRd regimen significantly improves minimal residual disease negativity, progression-free survival, and overall response in transplant-ineligible or transplant deferred patients with newly diagnosed multiple myeloma, establishing a new standard of care.

Patients 55

Patients 55

Pharmaceutical Commerce

DECEMBER 9, 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliancebut time to catch up on boosting the supply chains interoperable efforts.

FDA 52

FDA 52

Pharmacy Times

DECEMBER 9, 2024

The GMMG-HD7 trial evaluated the addition of isatuximab to standard induction therapy in patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation, demonstrating significantly higher rates of minimal residual disease negativity and improved progression-free survival (PFS).

Patients 55

Patients 55

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

PharmExec

DECEMBER 9, 2024

Real-world evidence from the largest analysis of second-line treatment with Yescarta in 2022-2023 demonstrated a high overall survival rate in patients with relapsed/refractory large b-cell lymphoma.

Patients 52

Patients 52

Pharmacy Times

DECEMBER 9, 2024

The primary challenge facing rural pharmacies include recruitment and retention of staff, the need for pharmacists to handle multiple roles and expertise, and the impact of burnout and stress.

Recruitment 52

Recruitment 52

PharmaTech

DECEMBER 9, 2024

The first CPHI Middle East event will be held Dec. 1012, 2024 at the Riyadh Front Exhibition & Convention Center Riyadh in Saudi Arabia and is expected to be host to 30,000 pharma professionals.

Manufacturing 52

Manufacturing Pharma 52

Pharmaceutical Commerce

DECEMBER 9, 2024

A cohort study of cancer drugs analyzes where the priorities of pricing policies should lie.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmExec

DECEMBER 9, 2024

Breakthrough designation was based on results from the TROPION-Lung05 Phase II trial with support from the TROPION-Lung01 Phase III trial of datopotamab deruxtecan in patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.

FDA 52

FDA Patients 52

Pharmaceutical Commerce

DECEMBER 9, 2024

Filling the gaps in the patient journey within an increasingly complex data environment.

Patients 52

Patients 52

PharmExec

DECEMBER 9, 2024

In this part of his Pharmaceutical Executive video interview, Bill Grambley, CEO of AllazoHealth, identifies which metrics and KPIs can be used to measure the effectiveness of AI-powered patient engagement and adherence programs.

Patients 52

Patients Pharmaceutical 52

Pharmaceutical Commerce

DECEMBER 9, 2024

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Joe Lipari, director of product management, Systech, predicts the probability that these DSCSA compliance deadlines put forth by the FDA will be met.

FDA 52

FDA Pharma Management 52

Advertiser: ZoomInfo

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.

Sales